Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held ...
Moderna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines.
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines - Global Strategic Business ... $20 Per Hour Minimum Wage Forcing Higher Prices In response to California's new $20 minimum ...
A lot has changed since SARS-CoV-2 (the virus responsible for COVID-19) appeared on the ... Pfizer’s and Moderna’s vaccines, which use mRNA technology, are approved for anyone 6 months and ...
While lockdowns and social distancing may feel like a distant memory, the COVID-19 virus is still with us. The latest vaccine offers the best protection for those who need it this spring.
It does this using technology that people may be familiar with from COVID vaccines. Moderna and Merck, who are developing this together, are taking the patient's tumor and doing genetic sequencing ...
Optimizing Boosters: How COVID ... century-old vaccine reduced tumors and extended survival for mice with liver ... Feb. 20, 2024 — A study has shown that shortly after an increase in ...
Moderna's COVID-19 Vaccine Safe and Effective for Young Children, Study Finds Nov. 4, 2022 — Moderna's COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical ...
In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited ...